Kevin W. Christensen, PhD is a director in BRG’s Washington, DC office. Dr. Christensen specializes in antitrust and competition policy, public policy, and damages analysis, often applied in the context of the pharmaceutical industry.
He regularly works on class action litigation matters to address questions of class certification and estimation of classwide damages. He has submitted expert reports to the US District Court for the District of Columbia and regulatory agencies. He has provided deposition testimony in state court. Additionally, he has written white papers submitted to the State of Florida’s Department of Transportation and drafted portions of new product applications submitted to the US Food and Drug Administration (FDA).
Dr. Christensen has been involved in antitrust and competition matters that included price fixing, monopoly and attempted monopoly, monopsony and attempted monopsony, market allocation, raising rivals costs, and tying and bundling allegations. He also has worked on several mergers and acquisitions and nonpublic investigations by federal agencies. For economic regulation matters, Dr. Christensen has estimated the economic and tax revenue impact of proposed infrastructure investments or regulatory changes. Finally, he has estimated economic damages in a variety of antitrust and false advertising litigations and has provided testimony on economic damages resulting from bribery. His work spans oil and gas, pharmaceutical, biotechnology, medical device, banking, automobile finance, wholesale distribution, transportation, consumer packaged goods (CPG), agriculture, building materials, tourism, and gaming industries.
Dr. Christensen holds a PhD and MA from the University of Florida and a BS from James Madison University, all in economics. Since 2011, he has been on the board of editors for The Antitrust Source, an online publication from the American Bar Association’s Section of Antitrust Law. For four years (2018–2021), he has been selected by Global Competition Review for its Who’s Who Legal: Competition – Future Leaders publication. The publication highlights experts in the field of competition economics under the age of forty-five. From 2018 to 2021, Dr. Christensen was a member of the James Madison University Economics Department Executive Advisory Board. He served as chair of the Advisory Board for two years. Currently, he is on the Board of Directors for RxPartnership, a part of the healthcare safety net that provides affordable brand and generic medications to low-income, uninsured Virginians.
Finance Scholars Group
2010 – 2012
The CapAnalysis Group, LLC
2006 – 2010
Ernst & Young, LLP
1998 – 2001
American Economic Association
National Association of Business Economists
American Bar Association
Areas of Expertise
University of Florida
PhD, Economics, 2006
MA, Economics, 2004
James Madison University
BS, Economics, 1998
Who’s Who Legal: Who’s Who Legal: Competition Future Leaders, Economists 2020
“Kevin Christensen is ‘held in very high regard’ for his top-tier economic research across an array of industries.”